DOI QR코드

DOI QR Code

Clinico-Pathological Profile and Haematological Abnormalities Associated with Lung Cancer in Bangalore, India

  • Baburao, Archana (Department of Pulmonary Medicine, Kempegowda Institute of Medical Sciences) ;
  • Narayanswamy, Huliraj (Department of Pulmonary Medicine, Kempegowda Institute of Medical Sciences)
  • Published : 2016.01.11

Abstract

Background: Lung cancer is one of the most common types of cancer causing high morbidity and mortality worldwide. An increasing incidence of lung cancer has been observed in India. Objectives:To evaluate the clinicpathological profile and haematological abnormalities associated with lung cancer in Bangalore, India. Materials and Methods: This prospective study was carried out over a period of 2 years. A total of 96 newly diagnosed and histopathologically confirmed cases of lung cancer were included in the study. Results: Our lung cancer cases had a male to female ratio of 3:1. Distribution of age varied from 40 to 90 years, with a major contribution in the age group between 61 and 80 years (55.2%). Smoking was the commonest risk factor found in 69.7% of patients. The most frequent symptom was cough (86.4%) followed by loss of weight and appetite (65.6%) and dyspnea (64.5%). The most common radiological presentation was a mass lesion (55%). The most common histopathological type was squamous cell carcinoma (47.9%), followed by adenocarcinoma (28.1%) and small cell carcinoma (12.5%). Distant metastasis at presentation was seen in 53.1% patients. Among the haematological abnormalities, anaemia was seen in 61.4% of patients, leucocytosis in 36.4%, thrombocytosis in 14.5% and eosinophilia in 19.7% of patients. Haematological abnormalities were more commonly seen in non small cell lung cancer. Conclusions: Squamous cell carcinoma was found to be the most common histopathological type and smoking still remains the major risk factor for lung cancer. Haematological abnormalities are frequently observed in lung cancer patients, anaemia being the commonest of all.

Keywords

Lung cancer;histopathology;smoking, haematological abnormalities;squamous cell carcinoma

References

  1. Alberg AJ, Ford JG, Samet JM (2007). Epidemiology of lung ACCP evidence-based clinical practice guidelines cancer. Chest, 132, 29-55. https://doi.org/10.1378/chest.07-1347
  2. Aoe K, Hiraki A, Ueoka H, et al (2004). Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration, 71, 170-73. https://doi.org/10.1159/000076679
  3. Bahader Y, Jazieh A (2008). Epidemiology of lung cancer. Ann Thorac Med, 3, 365-67.
  4. Behera D, Balamugesh T (2004). Lung cancer in India. Indian J Chest Dis Allied Sci, 46, 269-81.
  5. Ferlay J, Shin H R, Bray F, et al (2010). GLOBOCAN 2008. Cancer Incidence and mortality Worldwide: IARC Cancer Base No.10. International Agency for Research on cancer, Lyon, France.
  6. Ferrigno D, Buccheri G (2003). Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients. Monaldi Arch Chest Dis, 59, 193-98.
  7. Ganesh B, Sushma S, Monika S, et al (2011). A case control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev, 12, 357-62.
  8. Kasuga I, Makino S, Kiyokawa H, et al (2001). Tumour related leucocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer, 92, 2399-405. https://doi.org/10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W
  9. Khan NA, Afroz F, Lone MM, et al (2006). Profile of lung cancer in Kashmir, India-A five year study. Indian J Chest Dia Allied Sci, 48, 187-90.
  10. Khuder SA (2001). Effect of cigarette smoking on major histological types of lung cancer: a meta analysis. Lung cancer, 31, 139-48. https://doi.org/10.1016/S0169-5002(00)00181-1
  11. Langer CJ, Choy H, Glaspy JA, et al (2002). Standards of care for anemia management in oncology: focus on lung carcinoma. Cancer, 95, 613-23. https://doi.org/10.1002/cncr.10712
  12. Malik PS, Sharma MC, Mohanti BK, et al (2013). Clinocopathological profile of lung cancer at AIIMS: a changing paradigm in India. Asian Pac J Cancer Prev, 14, 489-94. https://doi.org/10.7314/APJCP.2013.14.1.489
  13. Mandal SK, Singh TT, SharmaTD, et al (2013). Clinicopathology of lung cancer in a regional cancer center in northeastern India. Asian Pac J Cancer Prev, 14, 7277-81. https://doi.org/10.7314/APJCP.2013.14.12.7277
  14. Pandit R, Scholnik A, Wulfekuhler L, et al (2007). Non- smallcell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol, 82, 234-37. https://doi.org/10.1002/ajh.20789
  15. Rawat J, Sindhwani G, Gaur D, et al (2009). Clinico-pathological profile of lung cancer. Lung India, 26, 74-76. https://doi.org/10.4103/0970-2113.53229
  16. Stafanie Heinemann, Peter Zabel, Hams-Peter Hauber (2008). Paraneoplastic syndromes in lung cancer. Cancer therapy, 6, 687-98.
  17. Thankappan KR, Thresia CU (2007). Tobacco use and social status in Kerala. Indian J Med Res, 126, 300-8.
  18. Vineis P, Alavanja M, Buffler P, et al (2004). Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst, 96, 99-106. https://doi.org/10.1093/jnci/djh014